Background Recent trials have suggested that maintenance treatments improve outcomes
for patients not progressing after first-line therapy for advanced non-small-cell lung cancer …

Objectives Although maintenance therapy has been a routine treatment paradigm for
advanced non-small cell lung cancer (NSCLC), there is currently lack of direct evidence to …

Evidence has suggested survival benefits of maintenance for advanced NSCLC patients not
progressing after first‐line chemotherapy. Additionally, particular first‐line targeted therapies …

Background The benefit of maintenance therapy has been confirmed in patients with non-
progressing non-small cell lung cancer (NSCLC) after first-line therapy by many trials and …

BACKGROUND: Maintenance therapy is a new treatment paradigm for advanced non-small
cell lung cancer (NSCLC). We conducted a meta-analysis of randomized studies with single …

Non-small cell lung cancer (NSCLC) is the leading cause of cancer death in the
industrialized world. Despite significant progress in early stage disease, survival rates for …

Background Can single-agent maintenance therapy be considered as an ideal strategy for
non-small cell lung cancer (NSCLC) treatment to achieve prolonged survival and tolerated …

Background Maintenance therapy for patients with non-small cell lung cancer (NSCLC) has
gained extensive interest. Varying results for this treatment underpin the need for a synthesis …

7553 Background: Maintenance therapy is a new treatment paradigm following first-line
combination chemotherapy for patients with advanced non-small cell lung cancer (NSCLC) …

Background Prospective studies have implied that maintenance therapy for non-small cell
lung cancer (NSCLC) has its effect by giving active drugs earlier to patients who otherwise …